[go: up one dir, main page]

MX2019015306A - Probioticos y metodos de uso. - Google Patents

Probioticos y metodos de uso.

Info

Publication number
MX2019015306A
MX2019015306A MX2019015306A MX2019015306A MX2019015306A MX 2019015306 A MX2019015306 A MX 2019015306A MX 2019015306 A MX2019015306 A MX 2019015306A MX 2019015306 A MX2019015306 A MX 2019015306A MX 2019015306 A MX2019015306 A MX 2019015306A
Authority
MX
Mexico
Prior art keywords
severity
microbial infection
methods
probiotics
lactating mother
Prior art date
Application number
MX2019015306A
Other languages
English (en)
Inventor
Romana Fasano Francesca
Rescigno Maria
Original Assignee
Heinz Co Brands H J Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinz Co Brands H J Llc filed Critical Heinz Co Brands H J Llc
Publication of MX2019015306A publication Critical patent/MX2019015306A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pediatric Medicine (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención presenta métodos para tratar o reducir la gravedad de una infección microbiana en un bebé de una madre lactante. Las composiciones comprenden productos alimenticios fermentados por Lactobacillus paracasei CBA L74, Depósito Internacional Número de Acceso LMG P-24778 que se administran a una madre embarazada o lactando con el fin de tratar o atenuar la gravedad de una infección microbiana en su descendencia.
MX2019015306A 2013-05-10 2015-11-09 Probioticos y metodos de uso. MX2019015306A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361821990P 2013-05-10 2013-05-10

Publications (1)

Publication Number Publication Date
MX2019015306A true MX2019015306A (es) 2020-02-17

Family

ID=51867774

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015015515A MX370692B (es) 2013-05-10 2014-05-09 Probióticos y métodos de uso.
MX2019015306A MX2019015306A (es) 2013-05-10 2015-11-09 Probioticos y metodos de uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015015515A MX370692B (es) 2013-05-10 2014-05-09 Probióticos y métodos de uso.

Country Status (15)

Country Link
US (3) US9980991B2 (es)
EP (2) EP2994150B1 (es)
CN (2) CN105209050B (es)
AU (2) AU2014262453B2 (es)
BR (1) BR112015028164B1 (es)
CA (1) CA2911496C (es)
DK (2) DK2994150T3 (es)
ES (2) ES2837384T3 (es)
MX (2) MX370692B (es)
NZ (1) NZ714202A (es)
PL (2) PL2994150T3 (es)
PT (2) PT3470074T (es)
RU (2) RU2018129984A (es)
TR (1) TR201908066T4 (es)
WO (1) WO2014183050A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
PT3901164T (pt) 2012-06-18 2025-02-13 Heinz Co Brands H J Llc Distúrbios relacionados com o glúten
RU2018129984A (ru) 2013-05-10 2019-03-15 Эйч. Джей. ХАЙНЦ КОМПАНИ БРЕНДС ЛЛСи Пробиотики и способы их применения
CA3090042A1 (en) * 2018-02-02 2019-08-08 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
US20220047651A1 (en) * 2018-12-19 2022-02-17 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
CN110305821B (zh) * 2019-08-28 2019-12-17 鲁东大学 副干酪乳杆菌配合car-t细胞治疗应用
WO2021062250A1 (en) 2019-09-25 2021-04-01 Tall Goods, Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof
KR102637723B1 (ko) * 2023-08-09 2024-02-19 이대훈 배변 기능 개선용 조성물 및 이를 포함하는 반려동물용 영양제

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1025140A (en) 1905-02-16 1912-05-07 Otis Elevator Co Potential switch.
US1025865A (en) 1910-10-13 1912-05-07 Hampden Watch Company Balance staff and roller for watches.
US1003929A (en) 1911-04-04 1911-09-19 Jacob T Lutz Trace-carrier.
US1024530A (en) 1911-08-02 1912-04-30 John Elmer Smith Watchmaker's tool.
EP0130228A1 (en) 1983-07-01 1985-01-09 Microlife Technics, Inc. Fermentation method using a selected lactobacillus
RU2134583C1 (ru) 1996-02-29 1999-08-20 Санкт-Петербургская государственная педиатрическая медицинская академия Способ санации женщин с массивной микробной обсемененностью грудного молока
WO1997049303A1 (en) 1996-06-21 1997-12-31 Quest International B.V. Fermentation of fruit products
SE510813C2 (sv) 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
SE522747C2 (sv) 1999-11-18 2004-03-02 Probi Ab Barnmatsprodukt
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
SE0003100D0 (sv) 2000-09-01 2000-09-01 Probi Ab New strains
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
KR100419132B1 (ko) 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
AU2003215272B2 (en) 2002-02-14 2008-04-03 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
ES2311729T5 (es) 2002-06-28 2013-02-14 Biosearch S.A. Cepas probióticas, un procedimiento para la selección de ellas, composiciones de las mismas y su uso
BRPI0415480B1 (pt) 2003-10-16 2019-09-17 Nestec S.A. Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia
CA2543626C (en) 2003-10-24 2013-08-27 N.V. Nutricia Synbiotic composition for infants
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
PT1629850E (pt) 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
CN101128129A (zh) 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
PT1898724E (pt) 2005-07-01 2010-11-26 Nutricia Nv Nutrição infantil com proteínas hidrolisadas
JP5242165B2 (ja) 2005-12-08 2013-07-24 キリンホールディングス株式会社 イソフムロン類包接体およびそれを含有する組成物
EP1839495B1 (en) 2006-03-27 2011-02-02 Nestec S.A. Protein-enriched frozen dessert
US20110165127A1 (en) 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
EP1893033B1 (en) 2006-07-07 2008-10-22 Alpro NV Method for preparing a dairy analogue
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
CN101451158A (zh) 2007-12-04 2009-06-10 黑龙江大学 副干酪乳杆菌产生的抗菌肽的分离纯化方法
EP2110027A1 (en) 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
AU2009253281A1 (en) 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2138187A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
WO2010002241A1 (en) 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010008272A1 (en) 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP3011843A1 (en) 2008-09-19 2016-04-27 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
EP2168444A1 (en) 2008-09-24 2010-03-31 Nestec S.A. Acidified nutritional formula
US9034314B2 (en) 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
EP2452574A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
US9462821B2 (en) 2008-12-08 2016-10-11 Nestec S.A. Modulation of infant fat mass
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
PL2413952T3 (pl) 2009-04-03 2017-08-31 Nestec S.A. Polepszenie promowania zdrowego doganiania wzrostu
EP2251021B1 (en) 2009-05-11 2012-02-22 Nestec S.A. Prevention and treatment of allergic diarrhoea
RU2556124C2 (ru) 2009-05-11 2015-07-10 Нестек С.А. Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
EA031179B1 (ru) 2010-03-12 2018-11-30 Компани Жервэ Данон Молочнокислые бактерии, применяемые при чревной болезни
EP2552464B1 (en) 2010-03-30 2018-02-28 Assistance Publique - Hôpitaux de Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011149335A1 (en) 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
CN102021127B (zh) 2010-07-28 2012-05-30 江南大学 一株副干酪乳杆菌及其应用
EP2449891A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449890A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2452572A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
RU2600877C2 (ru) 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
US20130143142A1 (en) 2011-09-28 2013-06-06 Georgia Tech Research Corporation Composite Solid Oxide Fuel Cell Electrolyte
PT3901164T (pt) 2012-06-18 2025-02-13 Heinz Co Brands H J Llc Distúrbios relacionados com o glúten
RU2018129984A (ru) 2013-05-10 2019-03-15 Эйч. Джей. ХАЙНЦ КОМПАНИ БРЕНДС ЛЛСи Пробиотики и способы их применения

Also Published As

Publication number Publication date
PT3470074T (pt) 2020-11-30
US20170065648A1 (en) 2017-03-09
CN105209050B (zh) 2019-11-12
MX370692B (es) 2019-12-19
AU2019226131B2 (en) 2020-07-16
RU2665637C2 (ru) 2018-09-03
RU2018129984A3 (es) 2022-04-06
CN105209050A (zh) 2015-12-30
CA2911496A1 (en) 2014-11-13
RU2018129984A (ru) 2019-03-15
EP3470074B1 (en) 2020-10-14
DK2994150T3 (da) 2019-06-11
ES2729641T3 (es) 2019-11-05
EP2994150B1 (en) 2019-03-06
HK1218247A1 (zh) 2017-02-10
EP2994150A1 (en) 2016-03-16
PL3470074T3 (pl) 2021-04-06
TR201908066T4 (tr) 2019-06-21
US9980991B2 (en) 2018-05-29
BR112015028164B1 (pt) 2022-02-08
PT2994150T (pt) 2019-06-14
US20180271920A1 (en) 2018-09-27
PL2994150T3 (pl) 2019-09-30
RU2015150082A3 (es) 2018-03-05
US10258656B2 (en) 2019-04-16
NZ714202A (en) 2021-07-30
AU2014262453A1 (en) 2015-12-03
ES2837384T3 (es) 2021-06-30
AU2014262453B2 (en) 2019-06-06
AU2019226131A1 (en) 2019-09-26
US20160113973A1 (en) 2016-04-28
CA2911496C (en) 2023-08-22
EP2994150A4 (en) 2016-11-16
BR112015028164A2 (pt) 2017-07-25
CN110651824A (zh) 2020-01-07
RU2015150082A (ru) 2017-06-16
DK3470074T3 (en) 2020-12-14
US10729733B2 (en) 2020-08-04
WO2014183050A1 (en) 2014-11-13
EP3470074A1 (en) 2019-04-17
MX2015015515A (es) 2016-05-26

Similar Documents

Publication Publication Date Title
MX2019015306A (es) Probioticos y metodos de uso.
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
PH12013501358A1 (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX367109B (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX355955B (es) Efecto antimicrobiano sinergico.
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
IN2015DN03862A (es)
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
IT1398553B1 (it) Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
EP3255140C0 (en) LACTIC ACID BACTERIA, NATURAL IMMUNOACTIVATOR AND INFECTION PREVENTIVE/THERAPEUTIC AGENT DERIVED FROM SAID LACTIC ACID BACTERIA AND FOOD/DRINK
PH12013500811A1 (en) Extruded non-replicating probiotic micro-organisms and their health benefits
PL3256009T3 (pl) Zmniejszanie stężenia bakterii gram-ujemnych w sfermentowanym produkcie spożywczym przy pomocy ekstraktu z czerwonego wina oraz kultury zawierającej co najmniej jeden szczep bakterii kwasu mlekowego wytwarzający bakteriocynę
PL2854826T3 (pl) Lactobacillus reuteri atcc pta 6475 do stosowania dla zapobiegania utracie kości u ssaków
GB2549400A (en) Creped prebiotic tissue
MX345948B (es) Uso de cepas mutantes resistentes a la nisina de lactobacilos para reducir la post-acidificación en los productos alimenticios.
NZ712617A (en) Bacterium belonging to genus lactobacillus
MX2015014687A (es) Bacterias acido lacticas.
WO2014191553A3 (en) Human plgf-2 for the prevention or treatment of heart failure
RU2013153056A (ru) Применение молочнокислых бактерий для улучшения органолептических свойств огурцов
UA33597U (ru) Способ профилактики и коррекции дисбиотических состояний у новорожденных, рожденных от матерей с герпесвирусной инфекцией
RU2013153063A (ru) Применение молочнокислых бактерий для улучшения органолептических свойств огурцов
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health
RU2013153042A (ru) Применение молочнокислых бактерий для улучшения органолептических свойств огурцов